Elekta (OTCMKTS:EKTAY) Shares Up 14.1% – Here’s What Happened

Elekta AB (OTCMKTS:EKTAY)’s share price rose 14.1% during trading on Friday . The company traded as high as $6.6910 and last traded at $6.6910. Approximately 370 shares changed hands during mid-day trading, a decline of 87% from the average daily volume of 2,746 shares. The stock had previously closed at $5.8650.

Elekta Stock Performance

The stock’s 50 day moving average price is $6.29 and its two-hundred day moving average price is $5.58. The company has a current ratio of 1.04, a quick ratio of 0.79 and a debt-to-equity ratio of 0.66. The firm has a market capitalization of $2.47 billion, a price-to-earnings ratio of 95.60 and a beta of 1.07.

Elekta (OTCMKTS:EKTAY) last announced its quarterly earnings data on Thursday, March 5th. The company reported $0.09 EPS for the quarter. Elekta had a net margin of 1.62% and a return on equity of 12.14%. The firm had revenue of $433.29 million during the quarter. On average, analysts forecast that Elekta AB will post 0.36 EPS for the current year.

Elekta Company Profile

Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.

The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.